Through a pan‐cancer analysis, we identified significant correlations between intratumoral microbiota diversity and TP53 mutation status, particularly in hepatocellular carcinoma (HCC) and endometrial cancer (EC). The gene discussed is TP53; the disease is endometrial cancer.